Sacha Schweikert
Overview
Explore the profile of Sacha Schweikert including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
520
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Carnegie V, Schweikert S, Anstey M, Wibrow B, Delaney A, Flower O, et al.
J Clin Neurosci
. 2022 Jul;
103:20-25.
PMID: 35802946
Our objective was to describe antiseizure medication (ASM) prescription patterns, and associations between ASM use and death and disability outcomes in patients with aneurysmal subarachnoid haemorrhage (aSAH) admitted to ICU....
2.
Cohen J, Delaney A, Anstey J, Anstey M, Barge D, Bellomo R, et al.
Crit Care Explor
. 2021 Jun;
3(6):e0445.
PMID: 34124687
Objectives: To investigate the association between plasma sodium concentrations and 6-month neurologic outcome in critically ill patients with aneurysmal subarachnoid hemorrhage. Design: Prospective cohort study. Setting: Eleven ICUs in Australia...
3.
Ali S, Schweikert S, Brusch A
BMJ Case Rep
. 2021 Jan;
14(1).
PMID: 33462002
Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome is an important cause of multi-organ dysfunction and can mimic other disorders including sepsis. We describe a patient presenting with septic...
4.
Udy A, Finnis M, Cohen J, Delaney A, Anstey J, Anstey M, et al.
J Clin Neurosci
. 2020 Dec;
82(Pt A):192.
PMID: 33317731
No abstract available.
5.
Angus D, Buzgau A, Cheng A, Higgins A, Hullegie S, Lawler P, et al.
JAMA
. 2020 Sep;
324(13):1317-1329.
PMID: 32876697
Importance: Evidence regarding corticosteroid use for severe coronavirus disease 2019 (COVID-19) is limited. Objective: To determine whether hydrocortisone improves outcome for patients with severe COVID-19. Design, Setting, And Participants: An...
6.
Dmytriw A, Maragkos G, Zuccato J, Singh J, Wilcox M, Schweikert S
Can J Neurol Sci
. 2019 May;
46(4):423-429.
PMID: 31113497
Introduction: Controversy exists in antiepileptic drug (AED) prophylaxis prescribing in patients with aneurysmal subarachnoid hemorrhage (SAH). We undertook the Use of Antiepileptic Drugs in Aneurysmal Subarachnoid Hemorrhage (ALIBI) study to...
7.
Udy A, Schweikert S, Anstey J, Anstey M, Cohen J, Flower O, et al.
Crit Care Resusc
. 2017 Jun;
19(2):103-109.
PMID: 28651504
Patients with an aneurysmal subarachnoid haemorrhage (SAH) frequently require admission to the intensive care unit. There, a variety of therapeutic strategies are initiated, in addition to definitive procedures aimed at...
8.
Marty R, Dirnhofer S, Mauermann N, Schweikert S, Akira S, Hunziker L, et al.
Circulation
. 2006 Jan;
113(2):258-65.
PMID: 16401773
Background: Experimental autoimmune myocarditis (EAM) is a CD4+ T-cell-mediated mouse model of postviral cardiomyopathy. Activation of interleukin-1 type 1 and Toll-like receptors that share the common downstream adaptor molecule MyD88...